Threonine News and Research

RSS
Research could pave way for more effective drugs to treat inflammation

Research could pave way for more effective drugs to treat inflammation

Denovo gains all rights from Lilly to develop, manufacture and commercialize enzastaurin drug

Denovo gains all rights from Lilly to develop, manufacture and commercialize enzastaurin drug

Research findings may lead to novel target for chemoresistant cancer cells

Research findings may lead to novel target for chemoresistant cancer cells

Researchers study LDLR protein using new, groundbreaking techniques

Researchers study LDLR protein using new, groundbreaking techniques

Co-targeting strategies suggested for EGFR-TKI resistance in NSCLC

Co-targeting strategies suggested for EGFR-TKI resistance in NSCLC

Neuroprotective effects of lithium are likely related to gene expressions

Neuroprotective effects of lithium are likely related to gene expressions

Ligand Pharmaceuticals, TG Therapeutics sign global license agreement for IRAK-4 inhibitors

Ligand Pharmaceuticals, TG Therapeutics sign global license agreement for IRAK-4 inhibitors

ArQule to present tivantinib clinical trial data at ASCO 2014

ArQule to present tivantinib clinical trial data at ASCO 2014

ArQule reports net loss of $7,141,000 in first quarter 2014

ArQule reports net loss of $7,141,000 in first quarter 2014

Exelixis presents final Phase 1b data on investigational MEK-BRAF inhibitor combination therapy for metastatic melanoma

Exelixis presents final Phase 1b data on investigational MEK-BRAF inhibitor combination therapy for metastatic melanoma

New drug is effective against superbug MRSA

New drug is effective against superbug MRSA

Researchers discover two genetic mutations associated with Familial Alzheimer's Disease

Researchers discover two genetic mutations associated with Familial Alzheimer's Disease

Promising early findings from Parkinson’s biomarker study

Promising early findings from Parkinson’s biomarker study

Oral toxicity is frequent limitation of mTOR therapy

Oral toxicity is frequent limitation of mTOR therapy

Lack or excess of CaM kinase II affects heart muscle cell stiffness

Lack or excess of CaM kinase II affects heart muscle cell stiffness

AKT1 genotype influences risk of psychotic disorders in cannabis users

AKT1 genotype influences risk of psychotic disorders in cannabis users

Anesthetics and protein interactions: an interview with José A. Fernández

Anesthetics and protein interactions: an interview with José A. Fernández

Oral BRAF inhibitor can extend survival to 16 months for patients with MM

Oral BRAF inhibitor can extend survival to 16 months for patients with MM

IKBKE protein plays two roles in tobacco-related NSCLC

IKBKE protein plays two roles in tobacco-related NSCLC

New approach may prevent septic shock

New approach may prevent septic shock